Search This Blog

Thursday, September 7, 2023

Elicio: Foundation Grant to Fund Research for Two Therapeutic Cancer Vaccines

 

  • Funds will advance research into ELI-007, a mutant BRAF-peptide vaccine, and ELI-008, a p53 hotspot mutation-peptide vaccine, with the aim of developing multivalent cancer vaccines targeting several mutations

  • This $2.6 million grant is an addition to the $2.8 million that GIRF awarded Elicio in September 2022

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)